• Login
    JavaScript is disabled for your browser. Some features of this site may not work without it.
    The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans 
    •   QMRO Home
    • Blizard Institute
    • Centre for Genomics and Child Health
    • The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
    •   QMRO Home
    • Blizard Institute
    • Centre for Genomics and Child Health
    • The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans
    ‌
    ‌

    Browse

    All of QMROCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    ‌
    ‌

    Administrators only

    Login
    ‌
    ‌

    Statistics

    Most Popular ItemsStatistics by CountryMost Popular Authors

    The IL23R R381Q Gene Variant Protects against Immune-Mediated Diseases by Impairing IL-23-Induced Th17 Effector Response in Humans

    View/Open
    TREMBATHTheIL23R2011FINAL.pdf (571.2Kb)
    Volume
    6
    Pagination
    ? - ?
    DOI
    10.1371/journal.pone.0017160
    Journal
    PLOS ONE
    Issue
    2
    ISSN
    1932-6203
    Metadata
    Show full item record
    Authors
    Di Meglio, P; Di Cesare, A; Laggner, U; Chu, CC; Napolitano, L; Villanova, F; Tosi, I; Capon, F; Trembath, RC; Peris, K
    URI
    http://qmro.qmul.ac.uk/xmlui/handle/123456789/5411
    Collections
    • Centre for Genomics and Child Health [667]
    Twitter iconFollow QMUL on Twitter
    Twitter iconFollow QM Research
    Online on twitter
    Facebook iconLike us on Facebook
    • Site Map
    • Privacy and cookies
    • Disclaimer
    • Accessibility
    • Contacts
    • Intranet
    • Current students

    Modern Slavery Statement

    Queen Mary University of London
    Mile End Road
    London E1 4NS
    Tel: +44 (0)20 7882 5555

    © Queen Mary University of London.